To this end, we quantified CD4 T cells reactive to lung adenocarcinoma antigens using IFN‐γ‐activated autologous monocyte‐derived DCs as antigen presenting cells, as described (Escors et al, 2008). This evidence concerns the gene CD4 and lung adenocarcinoma.